非洲盘尾丝虫病疫苗——TOVA——倡议 - Suppr

The Onchocerciasis Vaccine for Africa--TOVA--Initiative.

作者信息

Hotez Peter J, Bottazzi Maria Elena, Zhan Bin, Makepeace Benjamin L, Klei Thomas R, Abraham David, Taylor David W, Lustigman Sara

机构信息

Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, United States of America.

Institute of Infection and Global Health, University of Liverpool, Liverpool, England.

出版信息

PLoS Negl Trop Dis. 2015 Jan 29;9(1):e0003422. doi: 10.1371/journal.pntd.0003422. eCollection 2015 Jan.

DOI:10.1371/journal.pntd.0003422

PMID:25634641

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4310604/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d0/4310604/ada4b6451cab/pntd.0003422.g001.jpg

相似文献

The Onchocerciasis Vaccine for Africa--TOVA--Initiative.非洲盘尾丝虫病疫苗——TOVA——倡议

PLoS Negl Trop Dis. 2015 Jan 29;9(1):e0003422. doi: 10.1371/journal.pntd.0003422. eCollection 2015 Jan.

Programmatic goals and approaches to onchocerciasis.盘尾丝虫病的规划目标与方法

Lancet. 2000 May 13;355(9216):1663-4. doi: 10.1016/S0140-6736(00)02235-2.

[The campaign against onchocerciasis in Africa: update].[非洲盘尾丝虫病防治运动：最新情况]

Med Trop (Mars). 1998;58(3):285-96.

[Human onchocerciasis in Africa].[非洲的人类盘尾丝虫病]

Med Trop (Mars). 1997;57(4):389-400.

Epidemiology and control of onchocerciasis: the threshold biting rate of savannah onchocerciasis in Africa.盘尾丝虫病的流行病学和控制：非洲萨凡纳型盘尾丝虫病的阈值叮咬率。

Int J Parasitol. 2010 May;40(6):641-50. doi: 10.1016/j.ijpara.2009.10.016. Epub 2009 Nov 24.

River blindness. Protection for 54 cents a year.河盲症。每年54美分的防护费用。

UN Chron. 1998(1):12-3.

Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.非洲盘尾丝虫病控制：阈值变化、临界点和消除规则。

Int J Parasitol. 2011 Apr;41(5):581-9. doi: 10.1016/j.ijpara.2010.12.009. Epub 2011 Jan 19.

Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.发展中国家的盘尾丝虫病及其他眼部问题：验光师面临的一项挑战

J Am Optom Assoc. 1993 Oct;64(10):699-702.

Elimination of onchocerciasis from Africa: possible?从非洲消除盘尾丝虫病：是否可行？

Trends Parasitol. 2012 Jan;28(1):16-22. doi: 10.1016/j.pt.2011.10.003. Epub 2011 Nov 10.

Cutaneous onchocerciasis in an American traveler.

Int J Dermatol. 2005 Feb;44(2):125-8. doi: 10.1111/j.1365-4632.2004.02203.x.

引用本文的文献

Molecular insights into pangenome localization and constructs design for Hemophilus influenza vaccine.流感嗜血杆菌疫苗全基因组定位及构建设计的分子见解

Sci Rep. 2025 Jul 1;15(1):22316. doi: 10.1038/s41598-025-03536-0.

Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials.预测免疫信息学揭示了候选疫苗（Ov-RAL-2 和 Ov-103）具有良好的安全性和抗盘尾丝虫病的保护免疫反应特征，为即将进行的 I 期临床试验做准备。

PLoS One. 2024 Oct 21;19(10):e0312315. doi: 10.1371/journal.pone.0312315. eCollection 2024.

Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to in Mice and Non-Human Primates.佐剂融合蛋白疫苗在小鼠和非人灵长类动物中诱导对……的持久免疫力。（原文中“to”后面内容缺失）

Vaccines (Basel). 2023 Jul 6;11(7):1212. doi: 10.3390/vaccines11071212.

Ecological and socioeconomic factors associated with the human burden of environmentally mediated pathogens: a global analysis.与环境介导病原体所致人类负担相关的生态和社会经济因素：全球分析。

Lancet Planet Health. 2022 Nov;6(11):e870-e879. doi: 10.1016/S2542-5196(22)00248-0.

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With .从抗原发现推进人体盘尾丝虫病疫苗到针对牛自然感染的功效研究。

Front Cell Infect Microbiol. 2022 Apr 4;12:869039. doi: 10.3389/fcimb.2022.869039. eCollection 2022.

Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside.评估不同丝虫线虫对依美加群的体外敏感性。

Int J Parasitol Drugs Drug Resist. 2021 Dec;17:27-35. doi: 10.1016/j.ijpddr.2021.07.005. Epub 2021 Jul 28.

New global targets for NTDs in the WHO roadmap 2021-2030.世界卫生组织 2021-2030 年路线图中的新全球目标（NTDs）。

PLoS Negl Trop Dis. 2021 May 13;15(5):e0009373. doi: 10.1371/journal.pntd.0009373. eCollection 2021 May.

Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate against Onchocerciasis and Related Filarial Diseases.一种针对盘尾丝虫病及相关丝虫病的新型多表位候选疫苗的计算设计与初步血清学分析

Pathogens. 2021 Jan 21;10(2):99. doi: 10.3390/pathogens10020099.

NTDs in the 2020s: An epic struggle of effective control tools versus the Anthropocene.21世纪20年代的神经管缺陷：有效控制手段与人类世的一场史诗般的较量。

PLoS Negl Trop Dis. 2020 Sep 24;14(9):e0007872. doi: 10.1371/journal.pntd.0007872. eCollection 2020 Sep.

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans.针对疫苗抗原 Ov-103 和 Ov-RAL-2 的抗体反应与对感染旋盘尾丝虫的保护免疫力有关，这在小鼠和人类中均得到证实。

PLoS Negl Trop Dis. 2019 Sep 16;13(9):e0007730. doi: 10.1371/journal.pntd.0007730. eCollection 2019 Sep.

本文引用的文献

Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping.在罗阿丝虫与其他丝虫分布重叠地区评估严重不良事件风险的创新工具：微分层绘图的应用

Parasit Vectors. 2014 Jul 3;7:307. doi: 10.1186/1756-3305-7-307.

A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.一项随机、单剂量递增、伊维菌素对照、双盲的莫昔克丁治疗盘尾丝虫病的研究。

PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2953. doi: 10.1371/journal.pntd.0002953. eCollection 2014 Jun.

Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.实现《伦敦被忽视热带病宣言》中关于盘尾丝虫病的目标：增加非洲伊维菌素治疗频率的经济评估

Clin Infect Dis. 2014 Oct;59(7):923-32. doi: 10.1093/cid/ciu467. Epub 2014 Jun 18.

Vaccination with a genetically modified Brugia malayi cysteine protease inhibitor-2 reduces adult parasite numbers and affects the fertility of female worms following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae.用基因改造的马来布鲁线虫半胱氨酸蛋白酶抑制剂-2进行疫苗接种，在蒙古沙鼠（长爪沙鼠）经皮下接种马来布鲁线虫感染性幼虫后，可减少成虫寄生虫数量并影响雌虫的生育力。

Int J Parasitol. 2014 Sep;44(10):675-9. doi: 10.1016/j.ijpara.2014.05.003. Epub 2014 Jun 12.

Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.对抗河盲症的疫苗：在小鼠模型中针对盘尾丝虫感染的疫苗的表达、筛选及配方

Int J Parasitol. 2014 Aug;44(9):637-46. doi: 10.1016/j.ijpara.2014.04.006. Epub 2014 Jun 5.

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.围绕伊维菌素治疗对人体盘尾丝虫病的长期影响预测存在不确定性。

PLoS Negl Trop Dis. 2013 Apr 25;7(4):e2169. doi: 10.1371/journal.pntd.0002169. Print 2013.

African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.非洲盘尾丝虫病控制规划 1995-2015 年：模型估计的健康影响和成本。

PLoS Negl Trop Dis. 2013;7(1):e2032. doi: 10.1371/journal.pntd.0002032. Epub 2013 Jan 31.

Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes.删除寄生虫免疫调节序列并结合免疫激活信号可增强疫苗介导的对抗丝虫的保护作用。

PLoS Negl Trop Dis. 2012;6(12):e1968. doi: 10.1371/journal.pntd.0001968. Epub 2012 Dec 27.

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.在非洲流行区使用伊维菌素治疗消灭盘尾丝虫病的原理验证：马里和塞内加尔研究的最终结果。

PLoS Negl Trop Dis. 2012;6(9):e1825. doi: 10.1371/journal.pntd.0001825. Epub 2012 Sep 13.

A research agenda for helminth diseases of humans: intervention for control and elimination.人类寄生虫病研究议程：干预以控制和消除寄生虫病。

PLoS Negl Trop Dis. 2012;6(4):e1549. doi: 10.1371/journal.pntd.0001549. Epub 2012 Apr 24.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Onchocerciasis Vaccine for Africa--TOVA--Initiative.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献